Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Pharmaceutical composition for treatment of arthralgia, dermatosis and gynecopathy, preparation method and use thereof

A composition and skin disease technology, applied in the direction of drug combination, skin disease, pharmaceutical formula, etc., can solve the problems of lack of physical health care, women's diseases, inconvenience, etc., and achieve the effect of good clinical application prospects

Inactive Publication Date: 2018-01-05
甘孜州神螺藏医药研究开发中心
View PDF4 Cites 5 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, because many people lack proper understanding of gynecological diseases, lack of health care for the body, and various bad living habits, the physical health is deteriorating, causing some women to suffer from diseases that cannot be cured for a long time, which brings great harm to normal life and work. big inconvenience

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Pharmaceutical composition for treatment of arthralgia, dermatosis and gynecopathy, preparation method and use thereof
  • Pharmaceutical composition for treatment of arthralgia, dermatosis and gynecopathy, preparation method and use thereof
  • Pharmaceutical composition for treatment of arthralgia, dermatosis and gynecopathy, preparation method and use thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0031] Embodiment 1 The preparation of pharmaceutical composition pharmaceutical composition of the present invention

[0032] 1. Preparation method

[0033] Raw material formula:

[0034] Based on Juniper 60g, the dosage of other raw materials is: Rhododendron 130g, Artemisia grandis 60g

[0035]

[0036] Preparation Process:

[0037] (1) According to the formula of the raw material drug, 3 kilograms of the raw material drug are taken by weighing, pulverized, and mixed uniformly to obtain the raw material drug powder;

[0038] (2) Take 1 kg of highland barley, add 5 kg of water, cook, add 20 g of distiller's yeast, then add raw material medicine powder, mix well, seal, and ferment at 30-50 ° C for 5 days to obtain.

Embodiment 2

[0039] Embodiment 2 The preparation of pharmaceutical composition pharmaceutical composition of the present invention

[0040] Raw material formula:

[0041] Based on 130g of juniper, the dosage of other raw materials is: Rhododendron 60g, Artemisia grandis 130g

[0042]

[0043] Preparation Process:

[0044] (1) According to the formula of the raw material drug, 3 kilograms of the raw material drug are taken by weighing, pulverized, and mixed uniformly to obtain the raw material drug powder;

[0045] (2) Take 1 kg of highland barley, add 5 kg of water, cook, add 20 g of distiller's yeast, then add raw material medicine powder, mix well, seal, and ferment at 30-50 ° C for 5 days to obtain.

Embodiment 3

[0046] Embodiment 3 The preparation of pharmaceutical composition pharmaceutical composition of the present invention

[0047] Raw material formula:

[0048] Based on 100g of juniper, the dosage of the remaining raw materials is: Rhododendron 90g, Artemisia grandis 100g

[0049]

[0050] Preparation Process:

[0051] (1) According to the formula of the raw material drug, 3 kilograms of the raw material drug are taken by weighing, pulverized, and mixed uniformly to obtain the raw material drug powder;

[0052] (2) Take 1 kg of highland barley, add 5 kg of water, cook, add 20 g of distiller's yeast, then add raw material medicine powder, mix well, seal, and ferment at 30-50 ° C for 5 days to obtain.

[0053] The beneficial effects of the present invention will be specifically described below through test examples.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention provides a pharmaceutical composition for treatment of arthralgia, dermatosis and gynecopathy. The pharmaceutical composition is a preparation prepared from the following bulk drugs by weight: 60-130 parts of Juniperus formosana, 60-130 parts of Rhododendron anthopogonoides, 60-130 parts of Artemisia sieversiana, 60-130 parts of ephedra, 60-130 parts of Myricaria bracteata, 20-40 parts of polygonatum rhizome, 20-40 parts of radix asparagi, 20-40 parts of Chinese angelica, 20-50 parts of radix Mirabilis himalaicae, 20-50 parts of tribulus terrestris, 30-70 parts of amber, 30-70 parts of cassia seed, 30-70 parts of Hibiscus abelmoschus seeds, 20-50 parts of safflower, and 30-70 parts of Butea monosperma. The pharmaceutical composition provided by the invention has a precise andappropriate formula, has the efficacy of sweating, inflammation diminishing, pain relieving, alleviating yellow water, promoting blood circulation and dredging collaterals, can be used for arthralgia, i.e. rheumatic arthritis, rheumatoid arthritis, gout, hemiplegia, dermatosis, female postpartum diseases and the like, and has good clinical application prospect.

Description

technical field [0001] The invention relates to a pharmaceutical composition for treating arthralgia, skin diseases and gynecological diseases, a preparation method and application thereof. Background technique [0002] Arthralgia disease generally refers to the general term of related systemic diseases caused by the lack of righteousness of the body, weak defenses, wind, cold, dampness, heat and other evil forces taking advantage of the deficiency, resulting in stagnation of qi and blood, blockage of meridians and collaterals. The five viscera numbness, the six fu-organ numbness, the extraordinarily constant viscera numbness, and the five body and limb joint numbness mentioned in the "Nei Jing" reflect the basic content of the arthralgia disease. It can be seen that the arthralgia disease has a broad sense and a narrow sense. Those who are paralyzed are closed. Arthralgia in a broad sense refers to the diseases caused by the lack of righteousness of the body, the lack of e...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K36/8969A61P29/00A61P17/00A61P15/00A61P19/02A61P19/06A61P25/02A61P17/06A61P35/00A61P1/00A61P15/12A61K35/10
Inventor 白玛卓嘎江吉村强文社江华扎西彭措党知才仁白玛郎甲其麦英珠王盟
Owner 甘孜州神螺藏医药研究开发中心
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com